Monday Jan 31, 2022
Macrolides in COPD: Targeting airway inflammation
Professor Jodie Simpson joins Dr Richard Russell on the Medical Insider COPD podcast this week to discuss the management of airway inflammation in COPD. Listen as she explains the different types of airway inflammation and discusses the role of macrolides in COPD patient treatment.1–3 Dr Russell will then review an important recent publication on the effect of muscarinic antagonists on airway inflammation.4 As this week’s social media hot topic, he will be highlighting what patients with COPD think of the COVID-19 vaccination programme. Don’t miss out on new content, directly from the source to you!
1Global Initiative for Chronic Obstructive Lung Disease. Updated 2022. Available here. Last accessed: November 2021
2Simpson JL. Respirology 2020;25:47–48
3Simpson JL, et al. Respirology 2016;21:697–704
4Calzetta L, et al. Int J Chron Obstruct Pulmon Dis 2021;16:257–279
Disclosures
Professor Jodie Simpson
Professor Jodie Simpson has no disclosures.
Bios:
 |
Professor Jodie Simpson Professor Jodie Simpson (FThorSoc FERS) is the Deputy Director of the University of Newcastle's Priority Research Centre for Healthy Lungs, School of Medicine and Public Health, at the University of Newcastle, Australia. Jodie's work has significantly advanced the understanding of asthma, pathogenesis and therapeutic approaches. Her current research focuses on understanding the mechanisms of inflammation in asthma and COPD, and specifically on the role of airway phagocytes and bacterial colonisation. This work is complemented by her research investigating macrolide antibiotics as an anti-inflammatory therapy in asthma and COPD. |
This series of podcasts are intended for healthcare professionals only.
The Medical Insider COPD podcast series discusses hot topics in the world of COPD with those who know it best, aiming to spread information, debunk myths and improve the lives of patients. The Editorial Board of the Medical Insider COPD podcast is comprised of Professor James Chalmers, the British Lung Foundation Chair of Respiratory Research at the University of Dundee (UK), Professor Michael Dreher, the Head of the Department of Pneumology and Intensive Care Medicine at the University Hospital Aachen (Germany), and the host and moderator, Dr Richard Russell, a Consultant Chest Physician at Lymington New Forest Hospital (UK), a Senior Clinical Researcher at the University of Oxford (UK) and the founding editor of the International Journal of COPD. These series of podcasts have not been peer-reviewed, but have been vetted by the journal’s Editor-in-Chief.
Copyright © 2021, Boehringer Ingelheim Group of Companies. All rights reserved.